452 filings
Page 13 of 23
6-K
CLLS
Cellectis
6 Aug 19
Current report (foreign)
4:31pm
6-K
CLLS
Cellectis
6 Aug 19
Cellectis S.a. 6-K
4:30pm
6-K
CLLS
Cellectis
8 Jul 19
Cellectis S.a. 6-K
4:34pm
6-K
CLLS
Cellectis
26 Jun 19
Cellectis S.A. Reports Results from Combined Shareholders Meeting
4:53pm
6-K
CLLS
Cellectis
8 May 19
Current report (foreign)
12:00am
6-K
CLLS
Cellectis
7 May 19
Cellectis Reports Financial Results for First Quarter 2019
4:39pm
6-K
CLLS
Cellectis
3 May 19
Current report (foreign)
4:37pm
20-F/A
2018 FY
CLLS
Cellectis
25 Apr 19
Annual report (foreign) (amended)
9:09am
6-K
CLLS
Cellectis
17 Apr 19
Cellectis Announces Oral and Poster Presentations of Allogeneic CAR T-Cell Programs at the 2019 ASGCT Annual Meeting
4:27pm
6-K
CLLS
Cellectis
2 Apr 19
FDA Clears the IND for UCARTCS1, the First Allogeneic CAR-T to Treat Multiple Myeloma Patients
4:30pm
6-K
CLLS
Cellectis
12 Mar 19
Cellectis Reports 4th Quarter
12:00am
20-F
2018 FY
CLLS
Cellectis
Annual report (foreign)
11 Mar 19
9:54pm
6-K
CLLS
Cellectis
7 Mar 19
Cellectis Enters Lease Agreement to Build Manufacturing Facility, Advancing Towards Commercialization of its UCART Portfolio
4:32pm
6-K
CLLS
Cellectis
26 Feb 19
Cellectis Publishes Novel Methods to Improve the Safety of CAR T-Cell Therapy and Prevent CRS in the Journal of Biological Chemistry
12:00am
SC 13G/A
CLLS
Cellectis
13 Feb 19
Cellectis S.A.
11:48am
6-K
CLLS
Cellectis
10 Dec 18
Cellectis Appoints William Monteith as Senior Vice President U.S. Manufacturing
4:31pm
6-K
CLLS
Cellectis
13 Nov 18
Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2018
4:30pm
6-K
CLLS
Cellectis
13 Nov 18
Current report (foreign)
2:11pm
424B3
CLLS
Cellectis
15 Oct 18
Prospectus supplement
12:00am
S-8
CLLS
Cellectis
5 Oct 18
Registration of securities for employees
12:00am